All Articles

785 articles

Scientists Restore Memory in Mice by Blocking a Single Alzheimer's Protein
Brain Health

Scientists Restore Memory in Mice by Blocking a Single Alzheimer's Protein

Blocking the protein PTP1B boosted memory and cleared brain plaque in mice, with potential links to diabetes and obesity treatment.

Press Release
May 1, 2026 0
Common Grilled Chicken Contains More NDMA Than Drugs Pulled From Market
Nutrition & Diet

Common Grilled Chicken Contains More NDMA Than Drugs Pulled From Market

A carcinogen found in recalled meds like Zantac is present in higher amounts in a single serving of grilled chicken.

Press Release
May 1, 2026 0
FDA Moves to Ban Compounded GLP-1 Drugs Semaglutide and Tirzepatide
Longevity & Aging

FDA Moves to Ban Compounded GLP-1 Drugs Semaglutide and Tirzepatide

The FDA proposes removing semaglutide, tirzepatide, and liraglutide from the compounding bulks list, restricting cheaper alternatives.

Press Release
May 1, 2026 0
FDA Approves First Non-Antipsychotic Drug for Alzheimer's Agitation
Longevity & Aging

FDA Approves First Non-Antipsychotic Drug for Alzheimer's Agitation

Auvelity becomes the first non-antipsychotic FDA-approved treatment for agitation in Alzheimer's dementia, offering a new option for patients and caregivers.

Press Release
May 1, 2026 0
FDA Moves to Ban Compounded GLP-1 Drugs Semaglutide and Tirzepatide
Longevity & Aging

FDA Moves to Ban Compounded GLP-1 Drugs Semaglutide and Tirzepatide

The FDA proposes removing semaglutide, tirzepatide, and liraglutide from compounding lists, tightening access to cheaper GLP-1 alternatives.

Press Release
May 1, 2026 0
AI Detects Hidden Pancreatic Cancer Early Plus Key IBD and Liver Findings
Longevity & Aging

AI Detects Hidden Pancreatic Cancer Early Plus Key IBD and Liver Findings

A roundup of gastroenterology research covers AI cancer detection, IBD drug safety, GLP-1 combos for liver disease, and more.

Press Release
May 1, 2026 0
Modified CRISPR Tool Takes Aim at Down Syndrome Genetic Mutation
Regenerative Medicine

Modified CRISPR Tool Takes Aim at Down Syndrome Genetic Mutation

A redesigned CRISPR system targets the chromosomal root cause of Down syndrome, opening new doors for genetic disease intervention.

Press Release
May 1, 2026 0
EpiCRISPR Edits Genes Without Cutting DNA to Treat Muscle Disease
Regenerative Medicine

EpiCRISPR Edits Genes Without Cutting DNA to Treat Muscle Disease

Epicrispr's GEMS platform silences disease genes epigenetically โ€” reversibly and safely โ€” with a single viral vector, targeting FSHD and beyond.

Press Release
May 1, 2026 0
Labs Bet on Replacing Aged Cells and Organs Rather Than Repairing Them
Longevity & Aging

Labs Bet on Replacing Aged Cells and Organs Rather Than Repairing Them

A new perspective outlines how stem cells, bioprinted organs, and cross-species genes could replace โ€” not just repair โ€” aging biology.

Press Release
May 1, 2026 0
Sana Biotechnology's One-Shot Cell Therapy Could End Insulin Dependence for Type 1 Diabetics
Longevity & Aging

Sana Biotechnology's One-Shot Cell Therapy Could End Insulin Dependence for Type 1 Diabetics

Sana Biotechnology and Mayo Clinic are advancing SC451, a cell therapy that may restore natural insulin production without immunosuppression.

Press Release
May 1, 2026 0
New Obesity Drug Targets Fat Storage Instead of Appetite in Early Trials
Longevity & Aging

New Obesity Drug Targets Fat Storage Instead of Appetite in Early Trials

AT7687 blocks fat storage signals rather than suppressing hunger, showing early safety wins and metabolic benefits in first-in-human data.

Press Release
May 1, 2026 0
MIT Patent Deal Targets Alzheimer's Root Cause in ApoE4 Carriers via Cholesterol Fix
Longevity & Aging

MIT Patent Deal Targets Alzheimer's Root Cause in ApoE4 Carriers via Cholesterol Fix

Rafael Holdings licenses MIT patent for cyclodextrin therapy targeting cholesterol transport failure in ApoE4-linked Alzheimer's disease.

Press Release
May 1, 2026 0
PreviousPage 21 of 66Next